Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload

NCT03802916 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT03802916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload
Lead sponsor
ApoPharma
Phase
Phase 2
Overall status
Completed
Start date
March 6, 2019
Completion date
December 19, 2019
Enrollment
30 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload due to repeated red blood cell transfusions